Advertisement

Topics

KAMIYA BIOMEDICAL COMPANY Company Profile

05:33 EST 16th December 2018 | BioPortfolio

KAMIYA BIOMEDICAL COMPANY was founded by Kohji Kamiya in March of 1983 in Thousand Oaks, California, with the purpose of supplying the life science and medical communities with innovative laboratory research and diagnostic tools of the highest quality. KAMIYA is an independent American company that serves worldwide markets.
The companys first products were the cutting edge protein kinase inhibitors staurosporine and K252a for signal transduction research. In 1990, KAMIYA became the first company to introduce anti-Fas monoclonal antibodies to the U.S. research community. Since then, KAMIYA has become a leader in supplying quality apoptosis research products to the global market.

Location

12779 Gateway Drive
Seattle
Washington
98168
United States of America

Contact

Phone: (206) 575-8068
Fax: (206) 575-8094
Email: webmaster@kamiyabiomedical.com


News Articles [317 Associated News Articles listed on BioPortfolio]

New Bionow Service Company of the Year Award to recognise excellence in specialist biomedical service provision and submission deadline extension

Applications are invited from specialist biomedical service companies who meet the criteria detailed in the award application form available at http://www.bionow.co.uk/events/bionowannualawardsdinner....

Global Chorionic Gonadotropin Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Global Animal Hormones Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Aerie Pharmaceuticals and DSM Biomedical Expand Collaboration Agreement

Aerie Pharmaceuticals (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with ope...

AIVITA Biomedical enrols first patient in AV-GBM-1 trial

AIVITA Biomedical has enrolled the first patient in its Phase II clinical trial to evaluate AV-GBM-1 for the treatment of...Read More... The post AIVITA Biomedical enrols first patient in AV-GBM-1 tri...

Capillary Biomedical gets $2.9M boost

Capillary Biomedical has closed a round of seed financing led by Cove Fund, generating $2.9 million in proceeds.  -More- 

Aerie, DSM Biomedical expand drug-delivery R&D deal

Aerie Pharmaceuticals has secured an exclusive global license to DSM Biomedical's polyesteramide polymer technology for any n -More- 

Better biomedical devices, wearable displays may result from tiny light-guiding structures

For the first time, researchers have fabricated light-guiding structures known as waveguides just over one micron wide in a clear silicone commonly used for biomedical applications. The tiny, flexible...

PubMed Articles [325 Associated PubMed Articles listed on BioPortfolio]

Characteristics of Occupational Injuries in a Pharmaceutical Company in Iran.

To prioritize occupational hazards in a Pharmaceutical Company in Iran using the analytical hierarchy process (AHP).

A Man (or a Woman) is Known by the Company He/She Keeps.

Notes from the Field: Lead Exposures Among Employees at a Bullet Manufacturing Company - Missouri, 2017.

Exploiting Semantic Patterns over Biomedical Knowledge Graphs for Predicting Treatment and Causative Relations.

Identifying new potential treatment options for medical conditions that cause human disease burden is a central task of biomedical research. Since all candidate drugs cannot be tested with animal and ...

50 Anniversary Retrospective: Computers and Biomedical Research and Journal of Biomedical Informatics.

Clinical Trials [191 Associated Clinical Trials listed on BioPortfolio]

How Participants Perceive Biomedical Research in Pulmonology

The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Bigfoot Biomedical Clinical Research Center (CRC) Trial

The trial is designed to assess safety and feasibility of the Bigfoot Biomedical Type 1 Diabetes Management System (T1DMS) in up to 50 participants in a closely monitored Clinical Research...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Setting up a Warehouse of Physiological Data and Biomedical Signals in Adult Intensive Care

The aim of this study is the establishment of a warehouse physiological data and biomedical signal in intensive care adult patients in acute situations from particular records from the Phi...

Companies [2053 Associated Companies listed on BioPortfolio]

KAMIYA BIOMEDICAL COMPANY

KAMIYA BIOMEDICAL COMPANY was founded by Kohji Kamiya in March of 1983 in Thousand Oaks, California, with the purpose of supplying the life science and medical communities with innovative laboratory r...

Quertle, LLC

Quertle is a biomedical search engine focused on delivering informative results to biomedical researchers using advanced linguistic technologies, along with an in-depth und...

TARIS Biomedical LLC

TARIS Biomedical® is building a unique therapeutically-focused urology company, developing targeted new treatments for millions of patients suffering from difficult-to-treat ...

Gecko Biomedical

Gecko Biomedical is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of innovative polymers ...

Synergy Biomedical, LLC

Founded in 2011, Synergy Biomedical is a privately-held medical device company focused on bringing innovative biomaterial based products to the orthopaedic and spinal markets. The...

More Information about "KAMIYA BIOMEDICAL COMPANY" on BioPortfolio

We have published hundreds of KAMIYA BIOMEDICAL COMPANY news stories on BioPortfolio along with dozens of KAMIYA BIOMEDICAL COMPANY Clinical Trials and PubMed Articles about KAMIYA BIOMEDICAL COMPANY for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of KAMIYA BIOMEDICAL COMPANY Companies in our database. You can also find out about relevant KAMIYA BIOMEDICAL COMPANY Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record